Category

Cohort News

A first-in-human, prospective feasibility trial of a next-generation, shear-responsive, liquid embolic biomaterial, NeoCast featuring Arsenal Medical

//
Categories
Abstract Background NeoCastTM is a solvent-free, non-adhesive biomaterial engineered to achieve microvascular occlusion. EMBO-01 is the first-in-human trial of NeoCast for the pre-surgical embolization of hypervascular brain tumors supplied by the middle meningeal artery (MMA). Methods EMBO-01 was an open-label,...
Read More →

Sunflower Therapeutics’ results show how pairing Opera Bioscience’s bacterial secretion platform with continuous fermentation can open the door to longer runs and more efficient protein production

//
Categories
Sunflower Therapeutics shared its latest application note highlighting the successful continuous perfusion fermentation of a bacterial host using the Daisy Petal® Perfusion Bioreactor System. In collaboration with Opera Bioscience, the team cultivated Opera Bioscience’s proprietary gram-negative bacterial strain engineered to...
Read More →
1 2 3 165